Cargando…
Adherence to roflumilast under dose-escalation strategy in Korean patients with COPD
BACKGROUND: Frequent development of adverse events and consequent low adherence are major barriers in the wide use of roflumilast. Asian patients may be more susceptible to adverse events due to low BMI. In this study, we aimed to determine if a dose-escalation strategy is useful to improve the drug...
Autores principales: | Park, Tai Sun, Kang, Jieun, Lee, Jae Seung, Oh, Yeon-Mok, Lee, Sang-Do, Lee, Sei Won |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6580853/ https://www.ncbi.nlm.nih.gov/pubmed/31354255 http://dx.doi.org/10.2147/COPD.S191033 |
Ejemplares similares
-
Efficacy and Safety of Roflumilast in Korean Patients with COPD
por: Lee, Jae Seung, et al.
Publicado: (2016) -
Effect of a Dose-Escalation Regimen for Improving Adherence to Roflumilast in Patients with Chronic Obstructive Pulmonary Disease
por: Hwang, Hyunjung, et al.
Publicado: (2015) -
Bronchial Thermoplasty in Patients with Severe Uncontrolled Asthma: First Korean Cases
por: Kang, Jieun, et al.
Publicado: (2019) -
Comparison of Predicted Exercise Capacity Equations in Adult Korean Subjects
por: Jeong, Daehyun, et al.
Publicado: (2022) -
Dual versus monotherapy with bronchodilators in GOLD group B COPD patients according to baseline FEV(1) level: a patient-level pooled analysis of phase-3 randomized clinical trials
por: Kang, Jieun, et al.
Publicado: (2021)